Indeed, there are many reports indicating a relationship of circulating IGF-I with the disease, although no consensus has been reached on whether it exerts a beneficial or detrimental action [51], or could serve as a biomarker of the evolution of AD [52,53]. This evidence concerns the gene IGF1 and Alzheimer disease.